Molecular Science Corp. Receives GMP Licence From Health Canada

May 1, 2020
News

TORONTO, ON, May 1, 2020 – Molecular Science Corp. (MSC) is pleased to announce that it has been found in compliance with Good Manufacturing Practices (GMP) regulations, and has received its Drug Establishment Licence from Health Canada.

This significant milestone expands MSC’s current licensed capabilities to include the analysis of Active Pharmaceutical Ingredients (APIs) and pharmaceutical products, including the emerging pipeline of formulations containing extracted or synthesized cannabinoids, with the potential for driving growth beyond cannabis/cannabis-derived products.

“The GMP designation for MSC validates the company’s dedication to quality and compliance, and the experience of our team. It demonstrates to our customers that they can rely on our test results, and that we will continue to support them as they explore new markets and product categories that require GMP certification. It’s a key element in MSC’s strategy to add new, high value services to our repertoire and realize more value from our investments in highly skilled people and advanced instrumentation”, states Christian Carswell, CEO of MSC.

“Obtaining this licence proves that Quality was intertwined in our processes from the beginning. Quality is never an accident; it is the result of hard work, attention to detail and a great team”, says Sherry Farasami, Director of Quality Assurance at MSC.

Ensuring cannabis product safety and quality requires that analytical testing labs be held to a high standard in their methods and practices. MSC is committed to providing a level of service and operation that exceeds the standards set out by Health Canada and is focused on being among the leaders in analytical testing in Canada and globally.

About Molecular Science Corp.

Molecular Science Corp. (MSC) is a leading analytical services company focused exclusively on cannabis and cannabis-derived products, including pharmaceutical products containing extracted or synthesized cannabinoids. MSC operates a state-of-the-art, GMP laboratory in Toronto, Ontario under a Health Canada Analytical Testing License for cannabis and a Drug Establishment License. The company is dedicated to providing standard & micro-level Licensed Cultivators and Processors the tools and services they require to succeed with product quality.

For further information, please contact:

Mauro Aiello, Head of Labs & VP Lab Operations
Email:  maiello@mscience.ca

Or

Sherry Farasami, Director Quality Assurance

Email: sfarasami@mscience.ca

Past performance is not an indicator of future returns. Psychedelic Finance is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. Never make investment decisions based on anything Psychedelic Finance says. This message is meant for informational and educational purposes only and does not provide investment advice.